KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of HCWB
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Thursday for HCW Biologics Inc.
(Updated on Apr 25, 2024)

Sell candidate since Apr 19, 2024 Loss -4.58% PDF

The HCW Biologics Inc. stock price fell by -2.67% on the last day (Thursday, 25th Apr 2024) from $1.50 to $1.46. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 4.94% from a day low at $1.45 to a day high of $1.53. The price has fallen in 6 of the last 10 days and is down by -5.19% for this period. Volume has increased on the last day by 2 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 3 thousand shares were bought and sold for approximately $4.22 thousand.

Given the current short-term trend, the stock is expected to rise 42.88% during the next 3 months and, with a 90% probability hold a price between $2.09 and $2.91 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

HCWB Signals & Forecast

There are few to no technical positive signals at the moment. The HCW Biologics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.57 and $1.62. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, March 18, 2024, and so far it has fallen -17.51%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). HCW Biologics Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for HCW Biologics Inc. stock

HCW Biologics Inc. finds support from accumulated volume at $1.44 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0718 between high and low, or 4.94%. For the last week, the stock has had daily average volatility of 6.29%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (HCWB) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect HCW Biologics Inc. to open at $1.48, and during the day (based on 14 day Average True Range), to move between $1.33 and $1.59, which gives a possible trading interval of +/-$0.129 (+/-8.83%) up or down from last closing price. If HCW Biologics Inc. takes out the full calculated possible swing range there will be an estimated 17.67% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.44 (1.37%) than the resistance at $1.53 (4.79%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is HCW Biologics Inc. stock A Buy?

The HCW Biologics Inc. stock holds several negative signals and despite the positive trend, we believe HCW Biologics Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -1.814 Sell Candidate Unchanged

Predicted Opening Price for HCW Biologics Inc. of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
$1.48 ( 1.33%) $1.46

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for HCWB

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.55 6.25 %
R2 1.52 4.37 %
R1 1.51 3.21 %
Current price: 1.46
Support S1 1.45 -0.550 %
S2 1.44 -1.71 %
S3 1.41 -3.59 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.77 21.23 %
R2 1.70 16.44 %
R1 1.53 4.79 %
Current price 1.46
Support S1 1.44 -1.37%
S2 1.20 -17.81%
S3 1.18 -19.18%

FAQ

What is the symbol for HCW Biologics Inc. Stock and on which exchange is it traded?
The symbol for HCW Biologics Inc. is HCWB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell HCW Biologics Inc. Stock?
The HCW Biologics Inc. stock holds several negative signals and despite the positive trend, we believe HCW Biologics Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy HCW Biologics Inc. Stock?
HCW Biologics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy HCW Biologics Inc. Stock.

What's the current price of HCW Biologics Inc. Stock?
As of the end of day on the Apr 25, 2024, the price of an HCW Biologics Inc. (HCWB) share was $1.46.

What is the 52-week high and low for HCW Biologics Inc. Stock?
The 52-week high for HCW Biologics Inc. Stock is $2.32 and the 52-week low is $0.90.

What is the market capitalization of HCW Biologics Inc. Stock?
As of the Apr 25, 2024, the market capitalization of HCW Biologics Inc. is 55.222M.

When is the next earnings date for HCW Biologics Inc.?
The upcoming earnings date for HCW Biologics Inc. is May 14, 2024.
Click to get the best stock tips daily for free!

About HCW Biologics Inc.

HCW Biologics. HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as pulmonary fibrosis; and HCW9302 for auto-immune diseases, such as alopecia areata ... HCWB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT